SLXN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline ERII Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Reaction PSTV Q1 2026 Earnings WiderthanExpected Loss Reflects Ongoing RD Investment VTRS Q1 2026 Earnings Strong EPS Beat of 1517 Surprise Amid Stable Execution CRSR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Instil Bio Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment WHLR Q2 2024 Earnings EPS of 365 Strengthens as Stock Declines 136 Traws Pharma Inc TRAW Q1 2026 Earnings Narrower Net Loss Beats Estimates as Clinical Pipeline Advances HURN Q1 2026 Earnings EPS Beats Estimates as Consulting Services Maintain Momentum Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues AGNCP Q1 2026 Earnings Preferred Shares Benefit as EPS Exceeds Estimates by 145 ASRT Q1 2026 Earnings Significant EPS Miss Amid Revenue Disclosure Absence